BEN-MAIMON CAROLE 4
4 · Larimar Therapeutics, Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
Larimar (LRMR) CEO Carole Ben‑Maimon Receives RSU Awards
What Happened
Carole Ben‑Maimon, President, CEO and a director of Larimar Therapeutics (LRMR), was awarded a total of 700,700 restricted stock units (RSUs) on 2026-01-26. The filing shows two awards: 100,100 shares (acquired) and 600,600 shares reported as a derivative award, all at $0.00 (i.e., granted, not purchased). Per the filing, each RSU is a contingent right to receive one share of common stock upon settlement.
Key Details
- Transaction date: 2026-01-26; filing date: 2026-01-27 (timely).
- Awards: 100,100 RSUs (non-derivative) and 600,600 RSUs (derivative), total 700,700 RSUs; grant price reported $0.00.
- Shares owned after transaction: not specified in the provided filing details.
- Footnotes of note: F1 clarifies each RSU is a contingent right to one share on settlement. F2–F6 disclose certain shares are held in irrevocable trusts for family members for which Ms. Ben‑Maimon serves as trustee and she disclaims beneficial ownership except to the extent of any pecuniary interest.
- No sale or cash exercise occurred; this is an award/grant (transaction code A).
Context
RSUs are compensation awards that convert to actual shares only upon settlement (vesting or other conditions); they are not immediate cash purchases or sales and do not necessarily signal insider buying/selling intent. The derivative classification simply reflects a right to future shares. Retail investors should view this as an executive equity award rather than an open‑market purchase.
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Award
Common Stock
[F1]2026-01-26+100,100→ 368,276 total - Award
Stock Option (Right to Buy)
[F7]2026-01-26+600,600→ 600,600 totalExercise: $3.60Exp: 2036-01-26→ Common Stock (600,600 underlying)
Holdings
- 31,155(indirect: By Trust)
Common Stock
[F2] - 31,155(indirect: By Trust)
Common Stock
[F3] - 31,156(indirect: By Trust)
Common Stock
[F4] - 31,156(indirect: By Trust)
Common Stock
[F5] - 31,156(indirect: By Trust)
Common Stock
[F6]
Footnotes (7)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Meadow Lainey Ben-Maimon ("Meadow Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Meadow Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F3]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Olivia Liat Stein ("Olivia Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Olivia Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F4]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Ella Bar Stein ("Ella Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Ella Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F5]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Romi Aleeza Stein ("Romi Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Romi Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F6]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Matzi Mark Ben-Maimon ("Matzi Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Matzi Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F7]The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Signature
/s/ Jennifer Johansson, Attorney-in-fact|2026-01-27